CAPG and lung adenocarcinoma: The previous study demonstrated CapG lost exhibiting in the small-cell lung cancer (H69, Lu22, Lu139, Lu134, and H209), lung adenocarcinoma (PC7, RERF-LCMS), gastric cancer (AZ521), and melanoma (A2058) [14].